Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.

[1]  R. Pons,et al.  Santosomes as natural and efficient carriers for the improvement of phycocyanin reepithelising ability in vitro and in vivo. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  V. Lather,et al.  Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid , 2016, Drug delivery.

[3]  J. Wan,et al.  Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents , 2015, PloS one.

[4]  Yitao Wang,et al.  Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7 , 2015, Evidence-based complementary and alternative medicine : eCAM.

[5]  D. Atmani,et al.  Identification and nanoentrapment of polyphenolic phytocomplex from Fraxinus angustifolia: in vitro and in vivo wound healing potential. , 2015, European journal of medicinal chemistry.

[6]  C. Nguyen,et al.  1H NMR Spectroscopy as an Effective Method for Predicting Molecular Weight of Polyaminoamine Dendrimers and Their Derivatives , 2015 .

[7]  E. Mardis,et al.  AACR Cancer Progress Report 2014 , 2014, Clinical Cancer Research.

[8]  K. Anderson,et al.  AACR Cancer Progress Report 2014: Transforming Lives Through Research , 2014, Clinical Cancer Research.

[9]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[10]  A. Ray,et al.  Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. , 2013, International journal of pharmaceutics.

[11]  N. Picci,et al.  Isoniazid‐gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis , 2013, The Journal of pharmacy and pharmacology.

[12]  Rajiv Gupta,et al.  Bioavailability enhancers of herbal origin: an overview. , 2013, Asian Pacific Journal of Tropical Biomedicine.

[13]  A. Akbarzadeh,et al.  PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[14]  O. Díez,et al.  Composition Influence on Pulmonary Delivery of Rifampicin Liposomes , 2012, Pharmaceutics.

[15]  Qiao Liu,et al.  Radiosensitization effects of berberine on human breast cancer cells. , 2012, International journal of molecular medicine.

[16]  Xing Tang,et al.  Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats , 2011, AAPS PharmSciTech.

[17]  W. Han,et al.  The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  Prasanta Chowdhury,et al.  Kinetic modeling on drug release from controlled drug delivery systems. , 2010, Acta poloniae pharmaceutica.

[19]  N. K. Jain,et al.  Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice , 2010, Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[20]  B. Nanjwade,et al.  Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  S. Maiti,et al.  Dendritic effect of ligand-coated nanoparticles: enhanced apoptotic activity of silica-berberine nanoconjugates. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[22]  M. Gohel,et al.  Goodness-of-Fit Model-Dependent Approach for Release Kinetics of Levofloxacin Hemihydrates Floating Tablet , 2009 .

[23]  James R Baker,et al.  Dendrimer-based nanoparticles for cancer therapy. , 2009, Hematology. American Society of Hematology. Education Program.

[24]  Prateek Singh,et al.  Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. , 2008, Bioconjugate chemistry.

[25]  Abhay Asthana,et al.  Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient , 2005, AAPS PharmSciTech.

[26]  N. K. Jain,et al.  Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability. , 2008, Expert opinion on drug metabolism & toxicology.

[27]  Probal Banerjee,et al.  Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. , 2007, Organic letters.

[28]  Umesh Gupta,et al.  Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. , 2007, Biomaterials.

[29]  Mark W Grinstaff,et al.  Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. , 2006, Cancer research.

[30]  Anil K Patri,et al.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. , 2005, Advanced drug delivery reviews.

[31]  S. Jain,et al.  A PEGylated dendritic nanoparticulate carrier of fluorouracil. , 2003, International journal of pharmaceutics.

[32]  B. Stewart,et al.  World Cancer Report , 2003 .

[33]  B. Das,et al.  CONVERSION OF BERBERINE INTO BERBERRUBINE BY SELECTIVE DEMETHYLATION UNDER MICROWAVE IRRADIATION[1] , 2002 .

[34]  D J Newman,et al.  Natural products in drug discovery and development. , 1997, Journal of natural products.

[35]  J. Russo,et al.  Toward a physiological approach to breast cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.